Adham Jurdi

722 total citations
39 papers, 192 citations indexed

About

Adham Jurdi is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Adham Jurdi has authored 39 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cancer Research, 23 papers in Oncology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Adham Jurdi's work include Cancer Genomics and Diagnostics (29 papers), Genetic factors in colorectal cancer (17 papers) and Colorectal Cancer Treatments and Studies (9 papers). Adham Jurdi is often cited by papers focused on Cancer Genomics and Diagnostics (29 papers), Genetic factors in colorectal cancer (17 papers) and Colorectal Cancer Treatments and Studies (9 papers). Adham Jurdi collaborates with scholars based in United States, Japan and Taiwan. Adham Jurdi's co-authors include Vasily N. Aushev, Minetta C. Liu, Pashtoon Murtaza Kasi, Farshid Dayyani, Alexey Aleshin, Gregory P. Botta, Scott Kopetz, Saima Sharif, Shruti Sharma and Meenakshi Malhotra and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Adham Jurdi

35 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adham Jurdi United States	7	116	91	77	66	44	39	192
Filippo Pagani Italy	10	69 0.6×	194 2.1×	62 0.8×	148 2.2×	53 1.2×	27	284
Mustafa Karaağaç Türkiye	8	47 0.4×	142 1.6×	28 0.4×	69 1.0×	55 1.3×	51	229
Cristina Morelli Italy	8	37 0.3×	125 1.4×	42 0.5×	53 0.8×	54 1.2×	23	201
Tetsuji Terazawa Japan	9	32 0.3×	96 1.1×	29 0.4×	84 1.3×	39 0.9×	41	169
Aamir Ali Syed Pakistan	9	45 0.4×	134 1.5×	39 0.5×	66 1.0×	148 3.4×	55	278
Els Monsaert Belgium	6	87 0.8×	174 1.9×	24 0.3×	61 0.9×	60 1.4×	17	228
Calise K. Berger United States	6	103 0.9×	87 1.0×	34 0.4×	73 1.1×	93 2.1×	27	228
K. Moore Australia	6	107 0.9×	65 0.7×	96 1.2×	32 0.5×	91 2.1×	11	233
Dileep Mangira Australia	9	126 1.1×	183 2.0×	91 1.2×	146 2.2×	56 1.3×	13	312
Matthieu Delaye France	7	30 0.3×	171 1.9×	29 0.4×	61 0.9×	109 2.5×	33	220

Countries citing papers authored by Adham Jurdi

Since Specialization

Citations

This map shows the geographic impact of Adham Jurdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adham Jurdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adham Jurdi more than expected).

Fields of papers citing papers by Adham Jurdi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adham Jurdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adham Jurdi. The network helps show where Adham Jurdi may publish in the future.

Co-authorship network of co-authors of Adham Jurdi

This figure shows the co-authorship network connecting the top 25 collaborators of Adham Jurdi. A scholar is included among the top collaborators of Adham Jurdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adham Jurdi. Adham Jurdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Aiwu Ruth, Daniel A. Anaya, Jason W. Denbo, et al.. (2025). Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection. JCO Precision Oncology. 9(9). e2400443–e2400443. 5 indexed citations

Zaanan, Aziz, Audrey Didelot, Chloé Broudin, et al.. (2025). Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker study. Nature Communications. 16(1). 6815–6815. 1 indexed citations

Nakamura, Yoshiaki, Keiji Hirata, Naoya Akazawa, et al.. (2024). Prognostic and predictive value of ctDNA-based MRD and actionable biomarkers in patients with resectable colorectal cancer: CIRCULATE-Japan GALAXY.. Journal of Clinical Oncology. 42(16_suppl). 3609–3609.

Didelot, Audrey, Chloé Broudin, George Laliotis, et al.. (2024). Longitudinal circulating tumor DNA (ctDNA) analysis during treatment (Tx) of locally advanced resectable (LAR) gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (ADENOCA): The PLAGAST prospective biomarker study.. Journal of Clinical Oncology. 42(16_suppl). 4028–4028. 2 indexed citations

Lander, Eric, Vasily N. Aushev, Brandon M. Huffman, et al.. (2024). Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response. JCO Precision Oncology. 8(8). e2400288–e2400288. 1 indexed citations

Yukami, Hiroki, Yoshiaki Nakamura, Saori Mishima, et al.. (2024). Circulating tumor DNA (ctDNA) dynamics in patients with colorectal cancer (CRC) with molecular residual disease: Updated analysis from GALAXY study in the CIRCULATE-JAPAN.. Journal of Clinical Oncology. 42(3_suppl). 6–6. 11 indexed citations

Chakrabarti, Sakti, Stacey A. Cohen, Antony Tin, et al.. (2024). Prognostic value of circulating tumor DNA (ctDNA) testing in patients (pts) with rectal cancer after neoadjuvant therapy (NAT) and surgery.. Journal of Clinical Oncology. 42(3_suppl). 212–212. 1 indexed citations

White, Michael G., Beth A. Helmink, Samuel Rivero-Hinojosa, et al.. (2023). 649P The genomic landscape of appendiceal adenocarcinoma (AA) revealed by 855 whole exome sequences (WES). Annals of Oncology. 34. S455–S456. 1 indexed citations

Aushev, Vasily N., et al.. (2023). Evaluation of genomic alterations in early-onset versus late-onset colorectal cancer.. Journal of Clinical Oncology. 41(16_suppl). 3511–3511. 3 indexed citations

10.

Lander, Eric, et al.. (2023). Abstract 6696: Genomic alterations associated with early-onset and late-onset colorectal cancer. Cancer Research. 83(7_Supplement). 6696–6696. 1 indexed citations

11.

Lander, Eric, Brandon M. Huffman, Samuel J. Klempner, et al.. (2023). Circulating tumor DNA as a marker of recurrence risk in locoregional esophagogastric cancers with pathologic complete response.. Journal of Clinical Oncology. 41(4_suppl). 452–452. 3 indexed citations

12.

Abdelrahim, Maen, Abdullah Esmail, Aiwu Ruth He, et al.. (2023). 960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC). Annals of Oncology. 34. S600–S600. 2 indexed citations

13.

Molinari, Chiara, Giorgia Marisi, George Laliotis, et al.. (2023). 590P Assessment of circulating tumor (ct)DNA in patients (pts) with locally advanced rectal cancer (LARC) pts treated with neoadjuvant therapy (NAT). Annals of Oncology. 34. S428–S428. 4 indexed citations

14.

Mishima, Saori, Daisuke Kotani, Yoshiaki Nakamura, et al.. (2023). O4-5 Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: GALAXY study in the CIRCULATE-Japan. Annals of Oncology. 34. S1385–S1385.

15.

Cohen, Stacey A., Pashtoon Murtaza Kasi, Vasily N. Aushev, et al.. (2023). Kinetics of postoperative circulating cell-free DNA and impact on minimal residual disease detection rates in patients with resected stage I-III colorectal cancer.. Journal of Clinical Oncology. 41(4_suppl). 5–5. 11 indexed citations

16.

Dayyani, Farshid, Joseph Chao, Vasily N. Aushev, et al.. (2023). Circulating tumor DNA (ctDNA) informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers.. Journal of Clinical Oncology. 41(4_suppl). 427–427. 2 indexed citations

17.

Huffman, Brandon M., Vasily N. Aushev, Joseph Chao, et al.. (2022). Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers. JCO Precision Oncology. 6(6). e2200420–e2200420. 36 indexed citations

18.

Abdelrahim, Maen, Abdullah Esmail, Ashish Saharia, et al.. (2022). P-165 The feasibility of tumor recurrence detection in liver post-transplantation for patients with hepatocellular carcinoma via personalized, tumor-informed ctDNA testing. Annals of Oncology. 33. S308–S309. 4 indexed citations

19.

Alden, Stephanie, Charuta C. Palsuledesai, Adham Jurdi, et al.. (2022). Post-operative ctDNA monitoring in stage I colon cancer: A case report. Frontiers in Oncology. 12. 1074786–1074786. 1 indexed citations

20.

Jurdi, Adham, et al.. (2019). Melanoma and mantle cell lymphoma in a single collision tumor. Baylor University Medical Center Proceedings. 32(4). 584–586. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact